BECTON, DICKINSON AND COMPANY (BDX) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 272.39M; Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 272.39M | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 272.39M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 272.39M | (m) | (m) |
| 2026-03-31 | 275.54M | (m) | (m) |
| 2025-12-31 | 284.74M | (m) | (m) |
| 2025-09-30 | 285.42M | (m) | (m) |
| 2025-06-30 | 286.63M | (m) | (m) |
| 2025-03-31 | 286.61M | (m) | (m) |
| 2024-12-31 | 287.14M | (m) | (m) |
| 2024-09-30 | 289.12M | (m) | (m) |
| 2024-06-30 | 289.04M | (m) | (m) |
| 2024-03-31 | 289.01M | (m) | (m) |
| 2023-12-31 | 288.90M | (m) | (m) |
| 2023-09-30 | 290.41M | (m) | (m) |
| 2023-06-30 | 290.11M | (m) | (m) |
| 2023-03-31 | 284.01M | (m) | (m) |
| 2022-12-31 | 283.90M | (m) | (m) |
| 2022-09-30 | 283.38M | (m) | (m) |
| 2022-06-30 | 285.20M | (m) | (m) |
| 2022-03-31 | 285.06M | (m) | (m) |
| 2021-12-31 | 284.77M | (m) | (m) |
| 2021-09-30 | 284.02M | (m) | (m) |
| 2021-06-30 | 287.19M | (m) | (m) |
| 2021-03-31 | 290.82M | (m) | (m) |
| 2020-12-31 | 290.56M | (m) | (m) |
| 2020-09-30 | 290.03M | (m) | (m) |
| 2020-06-30 | 289.87M | (m) | (m) |
| 2020-03-31 | 271.78M | (m) | (m) |
| 2019-12-31 | 271.17M | (m) | (m) |
| 2019-09-30 | 270.46M | (m) | (m) |
| 2019-06-30 | 269.95M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |